Consistent with KEGG analysis, higher phenylalanine levels resulted in various metabolic disorders, such as drug, lipid, glutathione, and multiple signal pathway abnormalities, including MAPK and PI3K-AKT signaling pathways (Figure 7E). The gene discussed is AKT1; the disease is metabolic disease.